Последние добавленные видео:
Speaker:-Giuseppe-Saglio
-
2 года назад
132 2 года назад 16:34Giuseppe Saglio - The history of Chronic Myeloid Leukemia: from nightmare to the cure
-
2 года назад
52 2 года назад 3:09Giuseppe Saglio
-
2 года назад
53 2 года назад 26:45Giuseppe Saglio - State of the art and next questions in CML therapy
-
3 года назад
37 3 года назад 1:53Giuseppe Saglio INSIDE SOHO Italy
-
4 месяца назад
129 4 месяца назад 4:12The use of asciminib in the frontline treatment of CML
-
6 лет назад
657 6 лет назад 3:08Asciminib plus traditonal TKIs for chronic phase CML
-
4 месяца назад
21 4 месяца назад 1:04Prolonged follow-up of ASC4MORE: investigating the addition of asciminib to imatinib for CML
-
4 месяца назад
33 4 месяца назад 1:52Factors affecting adherence to TKI therapy in patients with CML
-
2 года назад
181 2 года назад 1:12The role of CML stem cells in relapse after TKI discontinuation & resistance to treatment
-
4 месяца назад
45 4 месяца назад 1:36Which patients with CML are suitable candidates for receiving asciminib?
-
4 месяца назад
79 4 месяца назад 1:29Commonly observed side effects with asciminib and how to manage them
-
6 лет назад
92 6 лет назад 5:29CML-IT-MOS: clinical characteristics of CML patients not included in clinical trials
-
2 года назад
58 2 года назад 3:20The current standard of care in CML and insights into the use of first- and second-generation TKIs
-
2 года назад
37 2 года назад 2:26An insight into the aims of the Eurasian Hematology-Oncology Group
-
9 лет назад
2352 9 лет назад 2:24The future of CML treatment and cures
-
2 года назад
175 2 года назад 1:51The potential of targeting dihydroorotate dehydrogenase in CML
-
6 лет назад
59 6 лет назад 2:15Resistance/intolerance to second generation TKIs in CML: what to do next?
-
2 года назад
98 2 года назад 2:11Addressing the issue of resistance to TKIs in CML